Bone health and therapeutic agents in advanced prostate cancer

Bone health and therapeutic agents in advanced prostate cancer

Prostate cancer is the most frequent genitourinary tumor worldwide. Maintaining an optimum bone health throughout the natural course of prostate cancer is an important aspect in the management of this disease, particularly in this at risk population of older and frail patients who experience bone lo...

Full description

Bibliographic Details
Main Authors: Maria Antonia Gómez-Aparicio, Fernando López-Campos, Lira Pelari-Mici, David Buchser, Jorge Pastor, Xavier Maldonado, Juan Zafra, Alison C. Tree, Renée Bultijnck, Paul Sargos, Piet Ost, Felipe Couñago
Format: Article
Language:English
Published: IMR Press 2022-01-01
Series:Frontiers in Bioscience-Landmark
Subjects:
bone health
prostate cancer
skeletal-related events
osteoporosis
denosumab
bisphosphonates
Online Access:https://www.imrpress.com/journal/FBL/27/1/10.31083/j.fbl2701034

Internet

https://www.imrpress.com/journal/FBL/27/1/10.31083/j.fbl2701034

Similar Items